These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 16888927

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Reliably combined to combat osteoporosis].
    MMW Fortschr Med; 2005 Dec 15; 147(51-52):63. PubMed ID: 16402714
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Osteoporotic fracture in menopausal women: alendronate reduces the risk].
    Bize R, Lamy O, Peytremann-Bridevaux I.
    Rev Med Suisse; 2008 Dec 10; 4(183):2703. PubMed ID: 19157286
    [No Abstract] [Full Text] [Related]

  • 7. [Effects of SERMs on bone health. Combination therapy with raloxifene].
    Gorai I, Hori H.
    Clin Calcium; 2010 Mar 10; 20(3):408-12. PubMed ID: 20190371
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Alendronate/vitamin D3 70 mg/2800 IU with and without additional 2800 IU vitamin D3 for osteoporosis: results from the 24-week extension of a 15-week randomized, controlled trial.
    Binkley N, Ringe JD, Reed JI, Ljunggren O, Holick MF, Minne HW, Liu M, Lamotta A, West JA, Santora AC.
    Bone; 2009 Apr 10; 44(4):639-47. PubMed ID: 19185560
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The patient's page. Bone health facts.
    McKinney J.
    South Med J; 2005 Oct 10; 98(10):1058. PubMed ID: 16295830
    [No Abstract] [Full Text] [Related]

  • 15. Changes in bone markers after once-weekly low-dose alendronate in postmenopausal women with moderate bone loss.
    Choi HJ, Im JA, Kim SH.
    Maturitas; 2008 Jun 20; 60(2):170-6. PubMed ID: 18572334
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [New medication for osteoporosis. To further increase instead of braking reduction].
    MMW Fortschr Med; 2003 Oct 30; 145(44):44. PubMed ID: 14655508
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.